Strand Life Sciences launches special test for early cancer detection

Test involves simple blood test with little discomfort, compared to biopsy, radioactive scans

Strand Life Sciences, a bioinformatics company, introduced liquid biopsy test portfolio called Strand LB that helps in highly sensitive detection of tumour traces from a simple blood draw.

While tumours are usually assessed through invasive biopsies or through radioactive scans, this test will ensure early and precise indication of tumour presence, cancer recurrence, and response to therapy, said the company in a statement.

Early detection of cancer will be essential as Indian Council of Medical Research suggests India is projected to have 1.73 million new cases of cancer reported by 2020 and more than 880,000 patients are expected to die from this